Previous Section
Clinical Trials
51. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
- Author
- Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU;
- Institution
- Institut Multidisciplinaire d'Oncologie, Clinique de Genolier, 1 route du Muids, Genolier, Switzerland. maapro@genolier.net
- Journal
- J Clin Oncol. 2008 Feb 1;26(4):592-8.
- Abstract URL
- Click here to view abstract
52. A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer.
- Author
- Gaui Mde F; Amorim G; Arcuri RA; Pereira G; Moreira D; Djahjah C; Biasoli I; Spector N;
- Institution
- Oncology and Pathology Services, National Cancer Institute, Rio de Janeiro, Brazil. mfgaui@hotmail.com
- Journal
- Am J Clin Oncol. 2007 Feb;30(1):78-81.
- Abstract URL
- Click here to view abstract
53. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
- Author
- Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G;
- Institution
- Department of Radiation Oncology, Henry Kaplan, Hopital Bretonneau, Tours, France. alain.toledano@gmail.com
- Journal
- J Clin Oncol. 2007 Feb 1;25(4):405-10.
- Abstract URL
- Click here to view abstract
54. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
- Author
- Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC;
- Institution
- Indiana University, 1111 Middle Drive NU340D, Indianapolis, Indiana 46202, USA. carpentj@iupui.edu
- Journal
- Oncologist. 2007 Jan;12(1):124-35.
- Abstract URL
- Click here to view abstract
55. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
- Author
- Smith I; Procter M; Gelber RD; Guillaume S; Feyereislova A; Dowsett M; Goldhirsch A; Untch M; Mariani G; Baselga J; Kaufmann M; Cameron D; Bell R; Bergh J; Coleman R; Wardley A; Harbeck N; Lopez RI; Mallmann P; Gelmon K; Wilcken N; Wist E; Sanchez Rovira P; Piccart-Gebhart MJ;
- Institution
- Royal Marsden Hospital, London, UK. ian.smith@rmh.nhs.uk
- Journal
- Lancet. 2007 Jan 6;369(9555):29-36.
- Abstract URL
- Click here to view abstract
56. Does patient satisfaction with breast reconstruction change over time? Two-year results of the Michigan Breast Reconstruction Outcomes Study.
- Author
- Alderman AK; Kuhn LE; Lowery JC; Wilkins EG;
- Institution
- Section of Plastic Surgery, Department of Surgery, The University of Michigan, Medical Center, Ann Arbor, MI 48109-0340, USA.
- Journal
- J Am Coll Surg. 2007 Jan;204(1):7-12. Epub 2006 Nov 16.
- Abstract URL
- Click here to view abstract
57. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
- Author
- Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta K; Kaufmann M;
- Institution
- Department of Obstetrics and Gynecology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
- Journal
- Ann Oncol. 2007 Jan 17;.
- Abstract URL
- Click here to view abstract
58. Depression and anxiety in women with breast cancer and their partners.
- Author
- Badger T; Segrin C; Dorros SM; Meek P; Lopez AM;
- Institution
- College of Nursing, Department of Communication, The University of Arizona, and Arizona Cancer Center, Arizona Health Science Center, Tucson 85721-0203, USA. Tbadger@nursing.arizona.edu
- Journal
- Nurs Res. 2007 Jan-Feb;56(1):44-53.
- Abstract URL
- Click here to view abstract
59. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
- Author
- Lee KS; Chung HC; Im SA; Park YH; Kim CS; Kim SB; Rha SY; Lee MY; Ro J;
- Institution
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, 809 Madu-1-dong, Ilsan-gu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.
- Journal
- Breast Cancer Res Treat. 2008 Mar;108(2):241-50. Epub 2007 May 3.
- Abstract URL
- Click here to view abstract
60. A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy.
- Author
- Clemons M; Dranitsaris G; Ooi W; Cole DE;
- Institution
- Division of Medical Oncology, Princess Margaret Hospital, Toronto, ON, Canada. mark.clemons@uhn.on.ca
- Journal
- Breast Cancer Res Treat. 2008 Mar;108(1):79-85. Epub 2007 May 2.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
